Adoptive cellular therapy with T cells specific for EBV-derived tumor antigens
Update Cancer Ther
.
2008 Mar;3(1):33-41.
doi: 10.1016/j.uct.2008.01.001.
Authors
John Craddock
1
,
Helen E Heslop
Affiliation
1
Center for Cell and Gene Therapy, Baylor College of Medicine, The Methodist Hospital and Texas Children's Hospital, Houston, TX.
PMID:
19255606
PMCID:
PMC2390887
DOI:
10.1016/j.uct.2008.01.001
No abstract available
Grants and funding
M01 RR000188-425043/RR/NCRR NIH HHS/United States
P01 CA094237-03/CA/NCI NIH HHS/United States
M01 RR000188-370531/RR/NCRR NIH HHS/United States
M01 RR000188/RR/NCRR NIH HHS/United States
P50 CA126752-01/CA/NCI NIH HHS/United States
M01 RR000188-400619/RR/NCRR NIH HHS/United States
P01 CA094237-04/CA/NCI NIH HHS/United States
M01 RR000188-390531/RR/NCRR NIH HHS/United States
M01 RR000188-425037/RR/NCRR NIH HHS/United States
M01 RR000188-350531/RR/NCRR NIH HHS/United States
M01 RR000188-360531/RR/NCRR NIH HHS/United States
P01 CA094237-01A1/CA/NCI NIH HHS/United States
T32 HL092332-06/HL/NHLBI NIH HHS/United States
K01 RR000188/RR/NCRR NIH HHS/United States
M01 RR000188-410619/RR/NCRR NIH HHS/United States
P01 CA094237-02/CA/NCI NIH HHS/United States
M01 RR000188-410608/RR/NCRR NIH HHS/United States
P01 CA094237-06/CA/NCI NIH HHS/United States
T32 HL092332/HL/NHLBI NIH HHS/United States
P01 CA094237-05/CA/NCI NIH HHS/United States
M01 RR000188-380531/RR/NCRR NIH HHS/United States
P50 CA126752/CA/NCI NIH HHS/United States
M01 RR000188-410598/RR/NCRR NIH HHS/United States
P01 CA094237/CA/NCI NIH HHS/United States